메뉴 건너뛰기




Volumn 80, Issue 4, 2013, Pages 434-435

Anti-Müllerian hormone: A marker for ovarian function in systemic lupus erythematosus patients treated with cyclophosphamide

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ESTRADIOL; FOLLITROPIN; INHIBIN B; MUELLERIAN INHIBITING FACTOR;

EID: 84880332237     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2012.10.016     Document Type: Letter
Times cited : (4)

References (8)
  • 1
    • 84860389172 scopus 로고    scopus 로고
    • Gonadotropin releasing hormone agonists may minimize cyclophosphamide associated gonadotoxicity in SLE and autoimmune diseases
    • Blumenfeld Z., Mischari O., Schultz N., et al. Gonadotropin releasing hormone agonists may minimize cyclophosphamide associated gonadotoxicity in SLE and autoimmune diseases. Semin Arthritis Rheum 2011, 41:346-352.
    • (2011) Semin Arthritis Rheum , vol.41 , pp. 346-352
    • Blumenfeld, Z.1    Mischari, O.2    Schultz, N.3
  • 2
    • 0010006795 scopus 로고    scopus 로고
    • Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy
    • Mok C.C., Lau C.S., Wong R.W. Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy. Arthritis Rheum 1998, 41:831-837.
    • (1998) Arthritis Rheum , vol.41 , pp. 831-837
    • Mok, C.C.1    Lau, C.S.2    Wong, R.W.3
  • 3
    • 8344248511 scopus 로고    scopus 로고
    • Significance of ovarian histology in the management of patients presenting a premature ovarian failure
    • Massin N., Gougeon A., Meduri G., et al. Significance of ovarian histology in the management of patients presenting a premature ovarian failure. Hum Reprod 2004, 19:2555-2560.
    • (2004) Hum Reprod , vol.19 , pp. 2555-2560
    • Massin, N.1    Gougeon, A.2    Meduri, G.3
  • 4
    • 80054026495 scopus 로고    scopus 로고
    • Using anti-Müllerian hormone to identify a good prognosis group in women of advanced reproductive age
    • Fridén B., Sjöblom P., Menezes J. Using anti-Müllerian hormone to identify a good prognosis group in women of advanced reproductive age. Aust N Z J Obstet Gynaecol 2011, 51:411-415.
    • (2011) Aust N Z J Obstet Gynaecol , vol.51 , pp. 411-415
    • Fridén, B.1    Sjöblom, P.2    Menezes, J.3
  • 5
    • 0036856434 scopus 로고    scopus 로고
    • Regulation of ovarian function: the role of anti-Müllerian hormone
    • Durlinger A.L., Visser J.A., Themmen A.P. Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction 2002, 124:601-609.
    • (2002) Reproduction , vol.124 , pp. 601-609
    • Durlinger, A.L.1    Visser, J.A.2    Themmen, A.P.3
  • 6
    • 44449098752 scopus 로고    scopus 로고
    • Relevance of anti-Mullerian hormone measurement in a routine IVF program
    • Gnoth C., Schuring A.N., Friol K., et al. Relevance of anti-Mullerian hormone measurement in a routine IVF program. Hum Reprod 2008, 23:1359-1365.
    • (2008) Hum Reprod , vol.23 , pp. 1359-1365
    • Gnoth, C.1    Schuring, A.N.2    Friol, K.3
  • 7
    • 62349083616 scopus 로고    scopus 로고
    • Anti-Müllerian hormone, inhibin B, and antral follicle count in young women with ovarian failure
    • Knauff E.A., Eijkemans M.J., Lambalk C.B., et al. Anti-Müllerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab 2009, 94:786-792.
    • (2009) J Clin Endocrinol Metab , vol.94 , pp. 786-792
    • Knauff, E.A.1    Eijkemans, M.J.2    Lambalk, C.B.3
  • 8
    • 63249137057 scopus 로고    scopus 로고
    • Assessment of ovarian function with anti-Müllerian hormone in systemic lupus erythematosus patients undergoing hematopoietic stem cell transplant
    • Browne H., Armstrong A., Decherney A., et al. Assessment of ovarian function with anti-Müllerian hormone in systemic lupus erythematosus patients undergoing hematopoietic stem cell transplant. Fertil Steril 2009, 91:1529-1532.
    • (2009) Fertil Steril , vol.91 , pp. 1529-1532
    • Browne, H.1    Armstrong, A.2    Decherney, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.